Micro Emerging Active

BMY Camzyos succès de l'essai de phase 3

New narrative with limited coverage — still forming.

Score
0,4
Vélocité
▲ 1,0
Articles
2
Sources
2

Sentiment Timeline

Event Timeline

Avr 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
Avr 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

Chronologie

Première observationAvr 02, 2026
Dernière mise à jourAvr 02, 2026